Fujitsu Launches AI-powered Physical Rehabilitation Solution 'HOPE ROMREC' in Japan
Automated system input for visual measurement and measured values of shoulder and elbow joint range of motion
TOKYO, Feb 24, 2021 - (JCN Newswire) - Fujitsu today announced the launch of a new AI-powered physical rehabilitation solution in Japan, the "FUJITSU Healthcare Solution HOPE ROMREC", offering medical institutions like hospitals and clinics a powerful new tool for rehabilitation and orthopedic therapies. The solution leverages a new AI technology to automatically measure the range of motion(1) of the shoulder and elbow joints from videos of patients' rehabilitation sessions.
|Fig. 1 Automatic detection of joint range of motion|
|Fig. 2 HOPE ROMREC Screen Image|
"HOPE ROMREC" is a solution that automatically measures, records, and visualizes the angles of a patient's shoulder and elbow by estimating a three-dimensional skeleton from rehabilitation videos captured using a tablet device(2). The solution leverages an image analysis AI engine developed by Fujitsu consisting of multiple AI image recognition models.
The technology offers the potential to greatly improve the efficiency of the visual measurement of a patient's joint curvature using a goniometer(3), a task conventionally performed by physical therapists and occupational therapists. Ultimately, the solution will help medical professionals evaluate the effectiveness of physical and occupational therapies and determine the degree of their patients' conditions.
Going forward, Fujitsu plans to continue strengthening the HOPE ROMREC solution and increase the number of measurement sites for range of motion detection. Fujitsu additionally plans to incorporate functions including automatic measurement of range of motion by simply sending video taken by a patient at home to their hospital or clinic, contributing to the realization of remote rehabilitation.
In rehabilitation therapy, measuring range of motion is necessary to determine factors inhibiting joint movement, evaluate the effects of physical and occupational therapy, and determine the extent of a patient's condition. Physical therapists and occupational therapists make these measurements visually using goniometers, etc., however, which contributes to variation in measurement values from person to person. Conventional automatic measurement of range of motion demands special equipment, such as an acceleration sensor, which have not yet been widely implemented in the field. In addition to the system input work of measurement values, therapists now must also carry out extensive disinfection in rehabilitation areas to prevent COVID-19 infections , increasing the burden on medical facilities.
To address these challenges, Fujitsu has developed the HOPE ROMREC solution, which automatically measures the range of motion of the shoulder and elbow joints by analyzing videos of patients' rehabilitation with AI. Sales of the new solution will begin in Japan on February 24.
Key Features of the New Solution
1. Automatic measurement of patient's range of motion with image analysis AI engine
Using an image analysis AI engine, which combines multiple AI image recognition models with previously learned motion patterns of a person's shoulder and elbow joints, it's possible to replicate a three-dimensional skeleton from a patient's rehabilitation video and automatically measure angles in a total of 16 motion directions for the shoulder and elbow. Therapists take the rehabilitation videos with a tablet's camera and send them to a dedicated PC equipped with an image analysis AI engine.
The measured values are recorded as data and can be displayed as a time-series line graph, making it easy to grasp the effect and transition of individual patients' rehabilitation.
It eliminates the need for accelerometers and joint markers on patients, as well as multiple cameras and specialized equipment such as infrared laser radar, which are required for conventional automated measurements of range of motion.
This greatly increases the efficiency of therapists' work, which uses goniometers to visually measure a patient's range of motion, and helps assess the effectiveness of physical and occupational therapy and determine the degree of the patient's condition.
2. Voice input function of the measured value
In order to reduce the workload of therapists in rehabilitation areas other than shoulders and elbows, for which measurements can be automatically taken for the range of joint motion from video, the system is equipped with a voice input function that enables the tablet to automatically record and recognize when the user speaks the body part, direction of movement, and measurement values measured by their goniometer.
This eliminates the need for note-taking and system input of measurement values that therapists typically perform, and enables measurement results to be recorded efficiently and quickly.
3. Easily link data with electronic medical records systems
Since the measurement data can be exported as CSV data, it can be easily incorporated into an electronic medical record system and a medical certificate preparation system, and it can be utilized for higher quality rehabilitation treatment based on the patient's treatment results and treatment plans.
(1) range of joint movement:
The maximum range of physical movement of each joint of the body, measured in degrees
(2) tablet device:
Presently available on iPad
Measurement device used by physical therapists, occupational therapists, etc. to measure range of joint movement.
Fujitsu is the leading Japanese information and communication technology (ICT) company offering a full range of technology products, solutions and services. Approximately 130,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.9 trillion yen (US$35 billion) for the fiscal year ended March 31, 2020. For more information, please see www.fujitsu.com.
Source: Fujitsu Ltd
Sectors: Artificial Intel [AI], MedTech
Copyright ©2021 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Press Release
More Latest Release >>
Hitachi Developed the Hitachi Electronic Signature Service that Promotes to Eliminate Personal Seals with High Authenticity of Information by Blockchain Technology, and Starts Internal Operations
Mar 03, 2021 11:48 JST
DENSO, KDDI Research 5G's use in Automated Driving to Achieve Safe and Secure Mobility
Mar 03, 2021 11:16 JST
Toyota Plans to Issue 'Woven Planet Bonds'
Mar 02, 2021 15:34 JST
Lockheed Martin and NEC Put AI to Work on Programs like NASA's Artemis Mission
Mar 02, 2021 14:03 JST
New Drug Approval for in-House Developed Anti-Insomnia Drug Dayvigo (Lemborexant) in Hong Kong
Mar 02, 2021 09:06 JST
Mitsubishi Power Commences Development of World's First Ammonia-fired 40MW Class Gas Turbine System
Mar 01, 2021 18:46 JST
MHI Machine Tool Develops Gear Shaping Machine for High-Precision Small-Module Gears Used in Robots
Mar 01, 2021 18:36 JST
Flying Finn Rovanpera Claims the Championship Lead in the Toyota Yaris WRC
Mar 01, 2021 10:46 JST
BYD to Help Kyoto Reach Japan's 2050 Carbon Neutral Goal
Feb 26, 2021 11:20 JST
Fujitsu and University of Toronto Researchers Develop Quantum-Inspired Technology to Optimize Radiation Treatment Plans for Brain Tumors and Other Diseases
Feb 26, 2021 10:59 JST
DENSO and Yamato Transport Develop D-mobico, Compact Mobile Refrigerator
Feb 25, 2021 19:28 JST
Mazda Production and Sales Results for January 2021
Feb 25, 2021 17:33 JST
Honda Reports Production, Sales and Export Results in January, 2021
Feb 25, 2021 15:27 JST
Toyota's Global Sales and Production Up Year-on-Year in January for Fifth Consecutive Month
Feb 25, 2021 15:12 JST
Chubu Miraiz and MC to Launch New Assisted-Living JV
Feb 24, 2021 14:12 JST
Fujitsu Launches AI-powered Physical Rehabilitation Solution 'HOPE ROMREC' in Japan
Feb 24, 2021 10:39 JST
Toyota Breaks Ground for 'Woven City'
Feb 23, 2021 13:43 JST
Eisai: MHLW Grants Orphan Drug Designation in Japan to Novel FGF Receptor Selective Tyrosine Kinase Inhibitor E7090
Feb 22, 2021 15:40 JST
Eisai Receives Corporate Philanthropy Award for Its Efforts to Realize Human Health Care (hhc) Philosophy
Feb 22, 2021 13:11 JST
Northgate Public Services Becomes NEC Software Solutions UK from July 2021
Feb 22, 2021 12:59 JST